Weight control: what's new? microbiome modulation - GLP-1

14/05/2025

Metabolic health - differentiate your weight management formula ABbiotek Health Fytexia Anzchem

At Vitafoods next week, weight control will be a major topic of the industry. For any brand aiming to lead GLP-1-related innovations, using high-quality, evidence-based, and versatile ingredients will be key.

Our company will introduce new scientific data on DNF-10, peptide-based ingredient for appetite control and Sinetrol, targeting fat loss for the long-term.

DNF-10 by Fytexia - Vitafoods 2025

DNF-10 is a patented peptide-based ingredient from Saccharomyces cerevisiae, which acts on the gut-brain mediation of appetite, to lower calorie intake and reduce body fat mass.

  • Fast-acting: significant reduction of calorie intake after the first few weeks of supplementation
  • Significant weight loss after the first month 
  • The weight lost comes from fat mass, lean mass is preserved
  • 500 mg/day for multiple delivery system applications

BOOK AN INTRODUCTION MEETING AT VITAFOODS

NEW DATA - MECHANISM OF ACTION

New mechanistic research has been conducted to understand the role of DNF-10 in reducing appetite, as measured in clinical trials. DNF-10 has been shown to modulate the enterohormones involved in appetite control—ghrelin, peptide YY, and cholecystokinin—and to enhance gut GLP-1 release.

DNF-10 by Fytexia - New mechanistic data 2025

 

DOWNLOAD THE BROCHURE

Sinetrol by Fytexia - Vitafoods 2025

Sinetrol provides polyphenols from citrus extracts acting at the adipocyte level to induce a healthy switch of the metabolism towards higher resting energy expenditure.

  • Amplifies natural thermogenesis helping to burn more calories at rest (+10%/day)
  • 100% of the weight lost comes from fat mass while preserving the lean mass 
  • 65% of the fat mass lost in the trunk area 
  • Proven sustainable weight loss

BOOK YOU MEETING AT VITAFOODS

NEW DATA - GUT MICROBIOTA & SINETROL INTERACTION DRIVES METABOLIC BENEFITS

A new open label study has been conducted on Sinetrol to study the dose-dependant effect and the relationship with gut microbiota. A beneficial shifts in microbiota towards an increase in SCFAs producers were inversely associated with changes in visceral adipose tissue.

DOWNLOAD THE PUBLICATION

Meet us at Vitafoods Barcelona 2025 - ABbiotek Health Fytexia Anzchem

This website is intended to provide information about Fytexia’s ingredients, used in various food/dietary supplement products around the world. It is only intended for business to business and to provide information to food/dietary supplement professionals and is not designed for the general public.  Statements used on this website have not been evaluated by the Food and Drug Administration or any other competent authority. Products are not intended to diagnose, treat, cure or prevent any disease.